DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.
DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 9, 2021 | Grant | $2.20M | 1 | National Human Genome Research Institute | — | Detail |
Oct 26, 2021 | Series C | $165M | 1 | — | — | Detail |
Jul 29, 2020 | Series B | $50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Human Genome Research Institute | Yes | Grant |
Agilent Technologies | — | Series C |